Neve RL

References (3)

Title : Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit - Hoilund-Carlsen_2024_Ageing.Res.Rev__102348
Author(s) : Hoilund-Carlsen PF , Alavi A , Barrio JR , Castellani RJ , Costa T , Herrup K , Kepp KP , Neve RL , Perry G , Revheim ME , Robakis NK , Sensi SL , Vissel B
Ref : Ageing Res Rev , :102348 , 2024
Abstract :
PubMedSearch : Hoilund-Carlsen_2024_Ageing.Res.Rev__102348
PubMedID: 38830549

Title : Nucleus accumbens CREB activity is necessary for nicotine conditioned place preference - Brunzell_2009_Neuropsychopharmacology_34_1993
Author(s) : Brunzell DH , Mineur YS , Neve RL , Picciotto MR
Ref : Neuropsychopharmacology , 34 :1993 , 2009
Abstract :
PubMedSearch : Brunzell_2009_Neuropsychopharmacology_34_1993
PubMedID: 19212318

Title : The RNA-binding protein HuD binds acetylcholinesterase mRNA in neurons and regulates its expression after axotomy - Deschenes-Furry_2007_J.Neurosci_27_665
Author(s) : Deschenes-Furry J , Mousavi K , Bolognani F , Neve RL , Parks RJ , Perrone-Bizzozero NI , Jasmin BJ
Ref : Journal of Neuroscience , 27 :665 , 2007
Abstract :
PubMedSearch : Deschenes-Furry_2007_J.Neurosci_27_665
PubMedID: 17234598